Status:
UNKNOWN
Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population
Lead Sponsor:
Universidade do Porto
Collaborating Sponsors:
Centro Hospitalar De São João, E.P.E.
Centro de Investigação em Tecnologias e Serviços de Saúde
Conditions:
Transthyretin Amyloidosis
Carpal Tunnel Syndrome
Eligibility:
All Genders
60+ years
Brief Summary
Systemic transthyretin amyloidosis is an aging-related disorder. It is usually associated with cardiac disease but also extends to other organs. Recent studies found that idiopathic carpal tunnel synd...
Eligibility Criteria
Inclusion
- . Patients aged ≥ 60 years old with symptomatic idiopathic carpal tunnel syndrome or other hand surgery indications.
Exclusion
- . Diabetes mellitus, hypothyroidism, hemodialysis, rheumatoid arthritis, and other inflammatory arthropathies, multiple myeloma, gout, chondrocalcinosis, Colles fracture, space-occupying lesions, and infectious synovitis.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05409833
Start Date
June 1 2020
End Date
June 1 2025
Last Update
October 19 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Hospitalar Universitário São João
Porto, Portugal, 4200-319
2
Faculty of Medicine (FMUP)
Porto, Portugal, 4200-319